Search
Feed aggregator
Who Will the Next “Big Pharma” Players Be?
Who Will the Next “Big Pharma” Players Be? 5/29/2024
How Realistic is AstraZeneca’s $80B Revenue Target by 2030?
How Realistic is AstraZeneca’s $80B Revenue Target by 2030? 5/29/2024
J&J Scores Phase III Victory in Major Depressive Disorder
J&J Scores Phase III Victory in Major Depressive Disorder 5/29/2024
Biopharma IPOs From the First Half of 2024
Biopharma IPOs From the First Half of 2024 5/29/2024
Can AI Help Biopharma Companies Go Green?
Can AI Help Biopharma Companies Go Green? 5/29/2024
AstraZeneca Touts Early-Stage Results for Oral PCSK9 Inhibitor
AstraZeneca Touts Early-Stage Results for Oral PCSK9 Inhibitor 5/29/2024
J&J Inks $1.25B Deal to Buy Rights to Atopic Dermatitis Candidate from Numab
J&J Inks $1.25B Deal to Buy Rights to Atopic Dermatitis Candidate from Numab 5/28/2024
Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics
Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics 5/28/2024
AstraZeneca, Daiichi Sankyo ADC Misses Endpoint in Phase III NSCLC Study
AstraZeneca, Daiichi Sankyo ADC Misses Endpoint in Phase III NSCLC Study 5/28/2024
NS Pharma’s DMD Candidate Viltespo Fails Confirmatory Phase III Trial
NS Pharma’s DMD Candidate Viltespo Fails Confirmatory Phase III Trial 5/28/2024
Novo Nordisk’s Once-Weekly Insulin Loses FDA Adcomm Vote for Type 1 Diabetes
Novo Nordisk’s Once-Weekly Insulin Loses FDA Adcomm Vote for Type 1 Diabetes 5/28/2024
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins 5/28/2024
30 Years After Genetic Discovery, Huntington’s Patients Still Waiting
30 Years After Genetic Discovery, Huntington’s Patients Still Waiting 5/28/2024
Despite Progress, ADCs Still Stalled in Non-Small Cell Lung Cancer
Despite Progress, ADCs Still Stalled in Non-Small Cell Lung Cancer 5/28/2024
Precision Medicine and Novel Approaches on Cusp of Breaking Through in Psychiatry
Precision Medicine and Novel Approaches on Cusp of Breaking Through in Psychiatry 5/28/2024
Opinion: How to Make Today’s Clinical Research More Efficient
Opinion: How to Make Today’s Clinical Research More Efficient 5/28/2024
Lilly Invests Another $5.3B in Indiana Plant to Boost Tirzepatide Manufacturing
Lilly Invests Another $5.3B in Indiana Plant to Boost Tirzepatide Manufacturing 5/24/2024
Novo Nordisk’s Semaglutide Cuts Death Risk in Diabetics with CKD in Phase III Trial
Novo Nordisk’s Semaglutide Cuts Death Risk in Diabetics with CKD in Phase III Trial 5/24/2024
ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial
ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial 5/24/2024
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study 5/24/2024
World Pharma News
- Up to one-third of antibody drugs are nonspecific
- More than 39 million deaths from antibiotic-resistant infections estimated between now and 2050
- How the immune system fails as cancer arises
- Laughter may be as effective as drops for dry eyes
- Pfizer highlights diverse oncology oortfolio and combination approaches at ESMO 2024